Search | IOVS | ARVO Journals

Showing 1 – 20 of 21

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

Electroretinography after long-term follow-up of selective retina therapy for macular edema.

Satoshi Honda; Manabu Yamamoto; Takeya Kohno; Kumiko Hirayama; Akika Kyo; Dirk Theissen-Kunde; Yoko Miura; Ralf Brinkmann; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):395. doi:

ARVO Annual Meeting Abstract July 2018

Predictive factors of selective retina therapy for diabetic macular edema

Kumiko Hirayama; Manabu Yamamoto; Takeya Kohno; Dirk Theissen-Kunde; Yoko Miura; Ralf Brinkmann; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4831. doi:

ARVO Annual Meeting Abstract June 2017

5-year outcome of initial treatment with ranibizumab monotherapy for polypoidal choroidal vasculopathy with good visual acuity

Takeya Kohno; Manabu Yamamoto; Tomoko Tamachi; Jyunji Asai; Natsuko Oishi; Shinsuke Ataka; Ayako Yasui; Akira Cho; Michiko Hirabayashi; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):880. doi:

ARVO Annual Meeting Abstract June 2017

One year outcome of treat and extend regimen of aflibercept for polypoidal choroidal vasculopathy

Tomoko Tamachi; Takeya Kohno; Akika Kyo; Manabu Yamamoto; Natsuko Oishi; Jyunji Asai; Shinsuke Ataka; Ayako Yasui; Akira Cho; Michiko Hirabayashi; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):885. doi:

ARVO Annual Meeting Abstract September 2016

2-year results of switching to aflibercept for polypoidal choroidal vasculopathy in patients refractory to ranibizumab

Takeya Kohno; Manabu Yamamoto; Akira Cho; Kumiko Hirayama; Ayako Yasui; Shinsuke Ataka; Michiko Hirabayashi; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):514. doi:

ARVO Annual Meeting Abstract September 2016

Two-year Results of “Treat and Extend” Intravitreal Aflibercept Injection for Exudative Age-related Macular Degeneration

Kyo Akika; Manabu Yamamoto; Ayako Yasui; Kumiko Hirayama; Takeya Kohno; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2667. doi:

ARVO Annual Meeting Abstract September 2016

Fundus Autofluorescence at Test Irradiation Spots after Selective Retina Therapy for Central Serous Chorioretinopathy.

Reina Okada; Manabu Yamamoto; Kumiko Hirayama; Ayako Yasui; Takeya Kohno; Dirk Theisen-Kunde; Yoko Miura; Ralf Brinkmann; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5345. doi:

ARVO Annual Meeting Abstract June 2015

Changes of Fundus Autofluorescence after Reduced Fluence Photodaynamic Therapy with Verteporfin in Patients with Central Serous Choroiretinopahty

Takeya Kohno; Manabu Yamamoto; Kumiko Yoshimoto; Akira Cho; Shogo Ogawa; Michiko Hirabayashi; Tomohiro Ikeda; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3729. doi:

ARVO Annual Meeting Abstract April 2014

Six-month results of switching to aflibercept for polypoidal choroidal vasculopathy in patients refractory to ranibizumab

Takeya Kohno; Manabu Yamamoto; Akira Cho; Yusaku Yoshida; Hisashi Iwami; Yuta Sawa; Kumiko Yoshimoto; Michiko Hirabayashi; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3839. doi:

ARVO Annual Meeting Abstract June 2013

Fundus autofluorescence at macular hole predicting postoperative visual acuities

tasuku yoneda; Manabu Yamamoto; Takeya Kohno; Yusaku Yoshida; Ayako Yasui; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):2814. doi:

ARVO Annual Meeting Abstract June 2013

Visual acuity loss at a two-year follow-up in patients with exudative age-related macular degeneration treated with ranibizumab and as needed retreatment basis

Takeya Kohno; Manabu Yamamoto; tasuku yoneda; Yusaku Yoshida; Hisashi Iwami; Mayumi Kaida; Michiko Hirabayashi; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3795. doi:

ARVO Annual Meeting Abstract June 2013

Focal Retinal Sensitivity Before and After Selective Retina Therapy for Central Serous Chorioretinopathy

Ayako Yasui; Manabu Yamamoto; Takeya Kohno; tasuku yoneda; Yusaku Yoshida; Hisashi Iwami; Dirk Theisen-Kunde; Yoko Miura; Ralf Brinkmann; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4130. doi:

ARVO Annual Meeting Abstract June 2013

Six-month Report of Selective Retina Therapy on Central Serous Chorioretinopathy in Japanese Patients

Manabu Yamamoto; Takeya Kohno; tasuku yoneda; Yusaku Yoshida; Hisashi Iwami; Ayako Yasui; Dirk Theisen-Kunde; Yoko Miura; Ralf Brinkmann; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4134. doi:

ARVO Annual Meeting Abstract March 2012

Aggravation Of Neovascular Age-related Macular Degeneration During The Induction Period Of Intravitreal Ranibizmab

Yusaku Yoshida; Takeya Kohno; Manabu Yamamoto; Yuta Sawa; Kumiko Yoshimoto; Mariko Yoneda; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):865. doi:

ARVO Annual Meeting Abstract March 2012

Fundus Autofluoresence and Spectral Domain OCT Findings at the Junction between the Altered and Normal Chorioretina in Patients with Tilted Disc Syndrome

Takeya Kohno; Manabu Yamamoto; Hisashi Iwami; Mayumi Kaida; Yuusaku Yoshida; Tasuku Yoneda; Michiko Hirabayashi; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1153. doi:

ARVO Annual Meeting Abstract March 2012

Detection Of Sub-threshold Laser Irradiation Spots With Various Fundus Imaging Methods And Its Correlation With Irradiation Energy And Optoacoustic Values In Selective Retina Therapy

Kumiko Yoshimoto; Manabu Yamamoto; Takeya Kohno; Tasuku Yoneda; Yusaku Yoshida; Andreas Fritz; Dirk Theisen-kunde; Yoko Miura; Ralf Brinkmann; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5198. doi:

ARVO Annual Meeting Abstract March 2012

Selective Retina Therapy for Patients with Central Serous Chorioretinopathy in Japan

Manabu Yamamoto; Takeya Kohno; Yusaku Yoshida; Tasuku Yoneda; Hisashi Iwami; Andreas Fritz; Dirk Theisen-Kunde; Yoko Miura; Ralf Brinkmann; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5222. doi:

ARVO Annual Meeting Abstract March 2012

The Treatment Of Chronic Central Serous Chorioretinopathy With Reduced Power Pdt

Mayumi Kaida; Takeya Kohno; Michiko Hirabayashi; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5399. doi:

ARVO Annual Meeting Abstract April 2011

Spectral Domain OCT Findings in Patients with Polypidal Choroidal Vasculopathy

Takeya Kohno; Manabu Yamamoto; Hisashi Iwami; Shinsuke Ataka; Mayumi Kaida; Michiko Hirabayashi; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2200. doi:

ARVO Annual Meeting Abstract April 2011

Fundus Autoflurescence Of Choroidal Neovascular Lesions In High Myopic Eyes Studied With Different Wavelengths Of Excitation Light Using Heidelberg Retina Angiogram And A Fundus Camera System

Megumi Yatera; Takeya Kohno; Manabu Yamamoto; Yusaku Yoshida; Tasuku Yoneda; Hisashi Iwami; Mayumi Kaida; Yoshio Okazaki; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2718. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Electroretinography after long-term follow-up of selective retina therapy for macular edema.

Predictive factors of selective retina therapy for diabetic macular edema

5-year outcome of initial treatment with ranibizumab monotherapy for polypoidal choroidal vasculopathy with good visual acuity

One year outcome of treat and extend regimen of aflibercept for polypoidal choroidal vasculopathy

2-year results of switching to aflibercept for polypoidal choroidal vasculopathy in patients refractory to ranibizumab

Two-year Results of “Treat and Extend” Intravitreal Aflibercept Injection for Exudative Age-related Macular Degeneration

Fundus Autofluorescence at Test Irradiation Spots after Selective Retina Therapy for Central Serous Chorioretinopathy.

Changes of Fundus Autofluorescence after Reduced Fluence Photodaynamic Therapy with Verteporfin in Patients with Central Serous Choroiretinopahty

Six-month results of switching to aflibercept for polypoidal choroidal vasculopathy in patients refractory to ranibizumab

Fundus autofluorescence at macular hole predicting postoperative visual acuities

Visual acuity loss at a two-year follow-up in patients with exudative age-related macular degeneration treated with ranibizumab and as needed retreatment basis

Focal Retinal Sensitivity Before and After Selective Retina Therapy for Central Serous Chorioretinopathy

Six-month Report of Selective Retina Therapy on Central Serous Chorioretinopathy in Japanese Patients

Aggravation Of Neovascular Age-related Macular Degeneration During The Induction Period Of Intravitreal Ranibizmab

Fundus Autofluoresence and Spectral Domain OCT Findings at the Junction between the Altered and Normal Chorioretina in Patients with Tilted Disc Syndrome

Detection Of Sub-threshold Laser Irradiation Spots With Various Fundus Imaging Methods And Its Correlation With Irradiation Energy And Optoacoustic Values In Selective Retina Therapy

Selective Retina Therapy for Patients with Central Serous Chorioretinopathy in Japan

The Treatment Of Chronic Central Serous Chorioretinopathy With Reduced Power Pdt

Spectral Domain OCT Findings in Patients with Polypidal Choroidal Vasculopathy

Fundus Autoflurescence Of Choroidal Neovascular Lesions In High Myopic Eyes Studied With Different Wavelengths Of Excitation Light Using Heidelberg Retina Angiogram And A Fundus Camera System

To View More...

You must be signed into an individual account to use this feature.